BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 12218575)

  • 1. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.
    Nicholson SA; Beasley MB; Brambilla E; Hasleton PS; Colby TV; Sheppard MN; Falk R; Travis WD
    Am J Surg Pathol; 2002 Sep; 26(9):1184-97. PubMed ID: 12218575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis.
    Wiatrowska BA; Krol J; Zakowski MF
    Diagn Cytopathol; 2001 Jan; 24(1):58-64. PubMed ID: 11135471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine and epithelial markers in diagnostic bronchial lung cancer biopsy specimens.
    Burnett HE; Zakhour HD; Walker C
    Eur J Cancer; 1992; 28A(4-5):853-5. PubMed ID: 1381930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
    Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
    Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural effusions due to small-cell lung carcinoma: a cytologic and immunocytochemical study.
    Chhieng DC; Ko EC; Yee HT; Shultz JJ; Dorvault CC; Eltoum IA
    Diagn Cytopathol; 2001 Dec; 25(6):356-60. PubMed ID: 11747231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of histopathologic subtype and stage in small cell lung cancer.
    Fraire AE; Johnson EH; Yesner R; Zhang XB; Spjut HJ; Greenberg SD
    Hum Pathol; 1992 May; 23(5):520-8. PubMed ID: 1314777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features.
    Crapanzano JP; Loukeris K; Borczuk AC; Saqi A
    Diagn Cytopathol; 2011 Feb; 39(2):92-100. PubMed ID: 21254456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.
    Travis WD; Linnoila RI; Tsokos MG; Hitchcock CL; Cutler GB; Nieman L; Chrousos G; Pass H; Doppman J
    Am J Surg Pathol; 1991 Jun; 15(6):529-53. PubMed ID: 1709558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of large cell component in small cell lung carcinoma by combined cytologic and histologic examinations and its clinical implication.
    Fushimi H; Kukui M; Morino H; Hosono Y; Fukuoka M; Kusunoki Y; Aozasa K; Matsumoto K
    Cancer; 1992 Aug; 70(3):599-605. PubMed ID: 1320448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased secretory leukoprotease inhibitor in patients with nonsmall cell lung carcinoma.
    Ameshima S; Ishizaki T; Demura Y; Imamura Y; Miyamori I; Mitsuhashi H
    Cancer; 2000 Oct; 89(7):1448-56. PubMed ID: 11013357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of neuroendocrine differentiation in lung cancer cell lines featured by cytomorphology, markers, and their corresponding tumors.
    Linnoila RI
    J Cell Biochem Suppl; 1996; 24():92-106. PubMed ID: 8806093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
    Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
    Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
    Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
    J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
    Schnabel PA; Junker K
    Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
    Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
    J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
    Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
    Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma from small cell carcinoma of the lung.
    Hoshi R; Furuta N; Horai T; Ishikawa Y; Miyata S; Satoh Y
    J Thorac Oncol; 2010 Apr; 5(4):472-8. PubMed ID: 20125039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.